Cooper Total Liabilities 2012-2026 | COO
Cooper total liabilities from 2012 to 2026. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Cooper total liabilities for the quarter ending January 31, 2026 were $4.156B, a 1.79% decline year-over-year.
- Cooper total liabilities for 2025 were $4.156B, a 1.79% decline from 2024.
- Cooper total liabilities for 2024 were $4.232B, a 3.01% increase from 2023.
- Cooper total liabilities for 2023 were $4.108B, a 4.86% decline from 2022.
|
Cooper Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2025 | $4,156 |
| 2024 | $4,232 |
| 2023 | $4,108 |
| 2022 | $4,318 |
| 2021 | $2,664 |
| 2020 | $2,913 |
| 2019 | $2,646 |
| 2018 | $2,805 |
| 2017 | $1,683 |
| 2016 | $1,783 |
| 2015 | $1,786 |
| 2014 | $1,870 |
| 2013 | $714 |
| 2012 | $728 |
| 2011 | $687 |
|
Cooper Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-10-31 | $4,156 |
| 2025-07-31 | $4,024 |
| 2025-04-30 | $4,126 |
| 2025-01-31 | $4,095 |
| 2024-10-31 | $4,232 |
| 2024-07-31 | $4,183 |
| 2024-04-30 | $4,244 |
| 2024-01-31 | $4,337 |
| 2023-10-31 | $4,108 |
| 2023-07-31 | $4,169 |
| 2023-04-30 | $4,162 |
| 2023-01-31 | $4,225 |
| 2022-10-31 | $4,318 |
| 2022-07-31 | $4,469 |
| 2022-04-30 | $4,764 |
| 2022-01-31 | $4,736 |
| 2021-10-31 | $2,664 |
| 2021-07-31 | $2,825 |
| 2021-04-30 | $2,851 |
| 2021-01-31 | $2,932 |
| 2020-10-31 | $2,913 |
| 2020-07-31 | $2,988 |
| 2020-04-30 | $2,883 |
| 2020-01-31 | $2,818 |
| 2019-10-31 | $2,646 |
| 2019-07-31 | $2,557 |
| 2019-04-30 | $2,661 |
| 2019-01-31 | $2,873 |
| 2018-10-31 | $2,805 |
| 2018-07-31 | $3,030 |
| 2018-04-30 | $3,226 |
| 2018-01-31 | $3,112 |
| 2017-10-31 | $1,683 |
| 2017-07-31 | $1,690 |
| 2017-04-30 | $1,810 |
| 2017-01-31 | $1,837 |
| 2016-10-31 | $1,783 |
| 2016-07-31 | $1,855 |
| 2016-04-30 | $1,856 |
| 2016-01-31 | $1,795 |
| 2015-10-31 | $1,786 |
| 2015-07-31 | $1,729 |
| 2015-04-30 | $1,777 |
| 2015-01-31 | $1,819 |
| 2014-10-31 | $1,870 |
| 2014-07-31 | $691 |
| 2014-04-30 | $660 |
| 2014-01-31 | $661 |
| 2013-10-31 | $714 |
| 2013-07-31 | $569 |
| 2013-04-30 | $630 |
| 2013-01-31 | $720 |
| 2012-10-31 | $728 |
| 2012-07-31 | $787 |
| 2012-04-30 | $591 |
| 2012-01-31 | $662 |
| 2011-10-31 | $687 |
| 2011-07-31 | $728 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.894B | $4.092B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |